MedPath

Assessment of swallowing function in patients with Head & Neck cancers treated using modern radiation technology.

Not Applicable
Conditions
Health Condition 1: null- Head & Neck Cancers
Registration Number
CTRI/2017/11/010442
Lead Sponsor
Tata Memorial Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Histologically proven head-neck Squamous Cell carcinoma

2.TNM stages T3-T4; N0-N2c; M0

3. Age >=18yrs and <=70yrs

4. Karnoffsky performance scale (KPS) >= 70 %

5.Planned for Definitive Concurrent Chemoradiotherapy.

6.Written informed consent

Exclusion Criteria

1.M1 disease

2.Primary tumor in nasopharynx/Paranasal Sinus/nasal cavity/salivary glands/unknown primary with neck node.

3. Post op patients/patients who have received any form of neoadjuvant therapy.

4. History of therapeutic irradiation to head and neck.

5. Pregnant / lactating women

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To objectively and subjectively assess the swallowing function in patients with locally advanced SCC of oropharynx, receiving concurrent chemotherapy and DARS sparing IMRT.Timepoint: After 2 years of completion of treatment
Secondary Outcome Measures
NameTimeMethod
Correlating the dose received by the individual DARS with the post treatment swallowing function. <br/ ><br> <br/ ><br>Timepoint: After 2 years of completion of treatment
© Copyright 2025. All Rights Reserved by MedPath